In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
1996 was a red-letter year for the art of speedrunning. Four years after Doom sparked the scene and months before Quake turned it into a global community, Resident Evil arrived to reward dedicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results